Categorizing and assessing negative symptoms

@article{Bucci2017CategorizingAA,
  title={Categorizing and assessing negative symptoms},
  author={Paola Bucci and Silvana Galderisi},
  journal={Current Opinion in Psychiatry},
  year={2017},
  volume={30},
  pages={201–208}
}
Purpose of review To provide a review on studies published in the last year relevant to the categorization and assessment of negative symptoms. Recent findings Recent research supported the validity of the ‘deficit/non-deficit schizophrenia’ categorization. Few studies confirmed the validity of the category ‘persistent negative symptoms’, whereas no recent study explored the validity of the category ‘predominant negative symptoms’. The two-factor structure of the negative dimension is supported… 
EPA guidance on assessment of negative symptoms in schizophrenia
TLDR
This European Psychiatric Association (EPA) guidance recommends the use of persistent negative symptoms (PNS) construct in the context of clinical trials and highlights the need for further efforts to make the definition of PNS consistent across studies in order to exclude as much as possible secondary negative symptoms.
Assessment of negative symptoms in male and female schizophrenia patients using the Polish version of the Brief Negative Syndrome Scale and Self-evaluation of Negative Symptoms
TLDR
The results indicate the existence of significant gender differences in the assessment of negative symptoms in three subscales of the Brief Negative Symptom Scale.
EPA guidance on treatment of negative symptoms in schizophrenia
TLDR
Recommendations for the treatment of undifferentiated negative symptoms (including both primary and secondary negative symptoms) are provided and although it has proven difficult to formulate an evidence-based recommendation for the choice of an antipsychotic, a switch to a second-generation antipsychotics should be considered.
The effectiveness and safety of cariprazine in schizophrenia patients with negative symptoms and insufficient effectiveness of previous antipsychotic therapy: an observational study
TLDR
Cariprazine significantly improved negative symptoms in schizophrenia patients in an open-label, flexible-dose, 16-week, observational study in Latvia.
Elucidating negative symptoms in the daily life of individuals in the early stages of psychosis
TLDR
Overall, altered affective experience, anhedonia, social an Shedonia and asociality seem to play less of a role in the daily life of individuals in the early stages of psychosis than previously assumed.
Disentangling the symptoms of schizophrenia: Network analysis in acute phase patients and in patients with predominant negative symptoms
TLDR
This network analysis suggests that symptoms of schizophrenia are differently structured in acute and PNS patients, and primary negative symptoms are better conceptualized as distinct negative symptom dimensions of the PANSS.
Long-term oral blonanserin treatment for schizophrenia: a review of Japanese long-term studies
TLDR
In conclusion, blonanserin is useful for long-term treatment of chronic schizophrenic patients when the appropriate management of clinical symptoms and adverse drug reactions are applied and may possibly fit both the current real-world clinical setting and the currently recommended approach to antipsychotics.
...
1
2
3
...

References

SHOWING 1-10 OF 89 REFERENCES
Self-Evaluation of Negative Symptoms: A Novel Tool to Assess Negative Symptoms.
TLDR
The results show that the SNS has good psychometric properties and satisfactory acceptance by patients, and the ability of patients with schizophrenia to accurately report their own experiences is demonstrated.
Psychometric evaluation of the negative syndrome of schizophrenia
TLDR
Current instruments for assessing the negative syndrome of schizophrenia were classified into two categories according to their content validity and assessment approach as first- or second-generation instruments, with the NSA being considered a transitional instrument between the two.
The structure of negative symptoms within schizophrenia: implications for assessment.
TLDR
Findings suggest that this construct is multidimensional with at least 2 factors (involving diminished expression and anhedonia-asociality) and the importance of employing assessments that provide adequate coverage of the broad domain of negative symptoms.
A Psychometric Comparison of the Clinical Assessment Interview for Negative Symptoms and the Brief Negative Symptom Scale.
TLDR
Comparisons of the Brief Negative Symptom Scale and Clinical Assessment Interview for Negative Symptoms suggest that both scales have good psychometric properties, but that there are important distinctions among the items related to motivation and pleasure.
Stability of the diagnosis of deficit syndrome in schizophrenia.
TLDR
These results provide evidence for the long-term stability of the deficit syndrome in patients with schizophrenia and the reliability of the deficits/nondeficit categorization when diagnosed by those with appropriate training by using cross-sectional and retrospective data.
...
1
2
3
4
5
...